Category: Patent Litigation

    By Suresh Pillai — Delaware District Court Invalidates Concerta® Patent The U.S. District Court for the District of Delaware has ruled that Watson Pharmaceuticals, Inc.'s generic version of Concerta® (methylphenidate hydrochloride extended-release tablets) does not infringe ALZA Corporation's and McNeill-PPC's patent covering the drug.  The District Court also invalidated the patent at issue, U.S.…

    By Suresh Pillai — Settlement Announced in SOLODYN® Patent Dispute Last week, Teva Pharmaceutical Industries Ltd. and Medicis Pharmaceutical Corp. entered into a settlement agreement that effectively ends a dispute between the two companies over the patent family covering SOLODYN® (minocycline HCL, used to treat acne) Extended Release Tablets.  Medicis' initial complaint, which was…

    By Suresh Pillai — Sepracor Settles Xopenex Suit With Barr Last week, Sepracor Inc. and Barr Pharmaceuticals, Inc. (a Teva Pharmaceuticals subsidiary) entered into a settlement agreement that effectively ends a dispute between the two companies over the patent family covering Xopenex®, an inhaled asthma treatment.  Sepracor's initial complaint against Barr, filed in July…

    By Suresh Pillai — Final Judgment Granted to Applera in Dispute with Enzo On March 5, the U.S. District Court for the District of Connecticut, upon the order of the Court of Appeals for the Federal Circuit (see "Biotech/Pharma Docket," March 2, 2009), reopened the patent litigation suit between Applera (based in Foster City,…

    By Suresh Pillai —Penwest and Endo Announce a Settlement of Opana® ER Litigation On February 20, Penwest Pharmaceuticals, based in Danbury, CT, and Endo Pharmaceuticals jointly announced a settlement of their litigation with Morristown, NJ-based Actavis South Atlantic LLC over the production and sale of generic formulations of Opana® ER (oxymorphone hydrochloride) (see "Court…

    By Suresh Pillai — King Pharmaceuticals' Patents on SKELAXIN® Invalidated By District Court In the case of King Pharmaceuticals, Inc. v. Eon Labs, Inc., the U.S. District Court for the Eastern District of New York invalidated two of the King patents at issue in the case, U.S. Patent Nos. 6,407,128 and 6,683,102 as part…

    By Suresh Pillai —GeoPharma and Dr. Reddy's Resolve Patent Litigation Related to Claritin® Patents On January 20, 2009, GeoPharma, based in Largo, FL, announced the settlement of its Clarinex® (Desloratadine) ANDA patent litigation with Schering-Plough (based in Kenilworth, NJ) and Sepracor (based in Marlborough, MA) (see "Court Report," February 24, 2008).  On February 20,…

    By Suresh Pillai — Oxford Gene Technology Settles Legal Action with Bioarray Solutions On January 21, 2009, Oxford, UK-based Oxford Gene Technology (OGT) announced a settlement of the patent infringement lawsuit OGT filed against BioArray Solutions, Ltd., a subsidiary of Immucor, a U.S. corporation based in Norcross, Georgia (see "Court Report," June 1, 2008). …

    By Donald Zuhn — Last week, the Law, Science & Technology Program at Stanford Law School announced the launch of the Stanford IP Litigation Clearinghouse (IPLC) Patent Litigation Module, a database of more than 23,000 cases filed in U.S. district courts since 2000.  According to the school's release, the publicly available, online database "will…